Get started
Author

Noa Phillips

ORCID: 0009-0004-7232-2364
Observed ORCID: 0009-0004-7232-2364
OpenAlex ID: A5111282011
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer
2025 · Karl Semaan, Rashad Nawfal, et al. · npj Precision Oncology · 8
PDF
Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinoma
2026 · Simon Garinet, Karl Semaan, et al. · Journal of Clinical Investigation · 7
Circulating kidney injury molecule-1 (KIM-1) in association with kidney injury biomarkers and outcomes in metastatic renal cell carcinoma.
2025 · Clara Steiner, Eddy Saad, et al. · Journal of Clinical Oncology · 4
PDF
SNAP: Streamlined Nextflow Analysis Pipeline for Immunoprecipitation-Based Epigenomic Profiling of Circulating Chromatin
2025 · Ze Zhang, Paulo Da Silva Cordeiro, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Integrated inference of cancer gene expression from cell-free plasma chromatin
2026 · Gunsagar S. Gulati, Damien Vasseur, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
48Immunotherapy response correlates in metastatic clear cell renal cell carcinoma from circulating cell-free epigenomes
2025 · Razane El Hajj Chehade, Karl Semaan, et al. · The Oncologist · 1
PDF
Epigenomic profiling of circulating chromatin for early detection and monitoring of neuroendocrine prostate cancer.
2025 · Karl Semaan, Rashad Nawfal, et al. · Journal of Clinical Oncology · 1
46 Radiological tumor burden is an independent risk factor for survival in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated with first line immunotherapy (IO)-based regimens
2024 · Rashad Nawfal, Marc Eid, et al. · The Oncologist · 1
Quantitative gene-level inference of tumor transcription from plasma epigenomes
2026 · Matthew Freedman, Gunsagar Gulati, et al. · Research Square
PDF
Use of NECTIN4 expression inferred from circulating chromatin to predict response and survival to enfortumab vedotin (EV) in metastatic urothelial carcinoma.
2026 · Rashad Nawfal, Gunsagar Singh Gulati, et al. · Journal of Clinical Oncology
Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identification
2026 · Karl Semaan, Marc Eid, et al. · medRxiv
Abstract 3848: Urine cell-free DNA methylation-based deconvolution identifies tumor-specific cell types in localized urinary tract cancers
2026 · Ze Zhang, Rashad Nawfal, et al. · Cancer Research
Genomic and proteomic predictors of sites of metastases in renal cell carcinoma.
2025 · Clara Steiner, Eddy Saad, et al. · Journal of Clinical Oncology
PDF
Abstract 5926: Determining classical-basal transcriptional subtypes of pancreatic ductal adenocarcinoma using circulating tumor DNA epigenomic profiling
2025 · Karl Semaan, Marc Eid, et al. · Cancer Research
HIF2α gene expression and clinical outcomes in patients with clear cell renal cell carcinoma with and without sarcomatoid differentiation.
2025 · Rashad Nawfal, Karl Semaan, et al. · Journal of Clinical Oncology
PDF
Correlates of immunotherapy response in metastatic clear cell renal cell carcinoma from circulating cell-free epigenomes.
2025 · Razane El Hajj Chehade, Karl Semaan, et al. · Journal of Clinical Oncology
Abstract B035: Detection and monitoring of translocation renal cell carcinoma via epigenomic profiling of cell-free DNA
2024 · Simon Garinet, Karl Semaan, et al. · Clinical Cancer Research
43 Epigenomic profiling of translocation renal cell carcinoma via liquid biopsy
2024 · Simon Garinet, Karl Semaan, et al. · The Oncologist
44 Liquid biopsy epigenomic profiling for the detection of sarcomatoid renal cell carcinoma
2024 · Karl Semaan, Talal El Zarif, et al. · The Oncologist
Impact of β-adrenergic blockade on efficacy of immunotherapy in patients with metastatic clear cell renal cell carcinoma.
2024 · Karl Semaan, Marc Eid, et al. · Journal of Clinical Oncology
PDF
Works count: 20
Citation count: 27
H-index: 3
I10-index:
Year
Topic
Type